Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

S&P Pharmaceuticals SPDR (XPH)

S&P Pharmaceuticals SPDR (XPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 179,119,000
  • Market Capitalization, $K 179,119
  • Shares Outstanding, K 5,100
  • 60-Month Beta 1.37
  • Price/Earnings ttm 11.44
  • Annual Dividend & Yield 0.30 (0.85%)
  • Most Recent Dividend 0.072 on 03/23/20
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.30 +14.88%
on 03/18/20
43.45 -19.88%
on 03/04/20
-6.83 (-16.40%)
since 03/03/20
3-Month
30.30 +14.88%
on 03/18/20
48.12 -27.66%
on 01/16/20
-10.10 (-22.49%)
since 01/03/20
52-Week
30.30 +14.88%
on 03/18/20
48.12 -27.66%
on 01/16/20
-6.89 (-16.52%)
since 04/03/19

Most Recent Stories

More News
Pharma ETFs Gain on Healthy Q4 Earnings

Strong results led to solid trading in pharma ETFs over the past week.

PPH : 52.62 (-0.64%)
PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

CSCO : 39.06 (-1.86%)
AMZN : 1,906.59 (-0.64%)
FB : 154.18 (-2.53%)
GOOG : 1,097.88 (-2.05%)
AAPL : 241.41 (-1.44%)
MSFT : 153.83 (-0.92%)
BBC : 27.66 (-1.32%)
XPH : 34.81 (-0.77%)
AXSM : 55.02 (-1.15%)
INTC : 54.13 (-0.40%)
CNST : 30.29 (+0.97%)
SAVA : 4.80 (-0.41%)
KOD : 43.13 (-1.35%)
RCEL : 5.49 (-5.43%)
4 Sector ETFs That Beat the Market in Q4

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

DIA : 210.60 (-1.57%)
SOXX : 195.98 (-1.89%)
IEZ : 5.93 (-1.50%)
BBC : 27.66 (-1.32%)
SMH : 112.04 (-2.00%)
PXJ : 1.7569 (-3.63%)
SIL : 23.80 (-2.94%)
XSD : 80.02 (-1.48%)
SBIO : 29.71 (-2.11%)
XPH : 34.81 (-0.77%)
QQQ : 183.37 (-1.42%)
SPY : 248.19 (-1.45%)
GNOM : 12.23 (-1.73%)
SILJ : 6.65 (-3.06%)
Pharma Sector Tops in October: Best ETFs & Stocks

Pharma sector wins in October, making these ETFs and stocks winners.

PPH : 52.62 (-0.64%)
XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
ALXN : 89.77 (-0.64%)
BIIB : 300.51 (-1.30%)
ACHN : 6.76 (+10.28%)
DERM : 18.75 (+0.05%)
GLYC : 2.11 (+1.44%)
RIGL : 1.4400 (+0.70%)
IRWD : 9.87 (-2.28%)
Pharma ETFs Set to Benefit Post Strong Q3 Earnings

Robust results led to solid trading in pharma ETFs in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
PPH : 52.62 (-0.64%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

Despite robust results, pharma ETFs have been trending downward in a month.

PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
PPH : 52.62 (-0.64%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
AbbVie to Buy Allergan: Prescribed ETFs

AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.

BMY : 55.53 (+0.58%)
AGN : 175.71 (-1.03%)
ABBV : 73.37 (-2.34%)
BBH : 128.32 (-0.77%)
PPH : 52.62 (-0.64%)
XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
PJP : 54.37 (-0.64%)
CELG : 108.24 (+0.10%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
PPH : 52.62 (-0.64%)
FTXH : 19.12 (-0.73%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
PPH : 52.62 (-0.64%)
FTXH : 19.12 (-0.73%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
PJP : 54.37 (-0.64%)
TGTX : 8.95 (-5.09%)
HZNP : 31.37 (-1.51%)
RKDA : 2.75 (-1.43%)
FTXH : 19.12 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Trade XPH with:

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 36.02
1st Resistance Point 35.41
Last Price 34.81
1st Support Level 34.27
2nd Support Level 33.74

See More

52-Week High 48.12
Fibonacci 61.8% 41.31
Fibonacci 50% 39.21
Fibonacci 38.2% 37.11
Last Price 34.81
52-Week Low 30.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar